Seres Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell MCRB and other ETFs, options, and stocks.About MCRB
Seres Therapeutics, Inc. engages in the development of biological drugs through microbiome therapeutics platform. Its product pipeline includes SER-109, SER-287, SER-301, and SER-401.
CEOEric D. Shaff
CEOEric D. Shaff
Employees233
Employees233
HeadquartersCambridge, Massachusetts
HeadquartersCambridge, Massachusetts
Founded2010
Founded2010
Employees233
Employees233
MCRB Key Statistics
Market cap122.14M
Market cap122.14M
Price-Earnings ratio-0.86
Price-Earnings ratio-0.86
Dividend yield—
Dividend yield—
Average volume3.12M
Average volume3.12M
High today$0.7982
High today$0.7982
Low today$0.7616
Low today$0.7616
Open price$0.787
Open price$0.787
Volume3.02M
Volume3.02M
52 Week high$6.87
52 Week high$6.87
52 Week low$0.7324
52 Week low$0.7324
MCRB News
Yahoo Finance 21h
Increases to Seres Therapeutics, Inc.'s CEO Compensation Might Cool off for now - Yahoo FinanceKey Insights Seres Therapeutics' Annual General Meeting to take place on 4th of April CEO Eric Shaff's total compensation includes salary of US$685.0k Total...
Simply Wall St 6d
Benign Growth For Seres Therapeutics, Inc. Underpins Stock's 30% Plummet - Simply Wall StUnfortunately for some shareholders, the Seres Therapeutics, Inc. ( ) share price has dived 30% in the last thirty days, prolonging recent pain. The recent drop...
Analyst ratings
71%
of 7 ratingsBuy
71.4%
Hold
14.3%
Sell
14.3%